| Tag | Content |
|---|
EnhancerAtlas ID | HS134-05464 |
Organism | Homo sapiens |
Tissue/cell | Mesendoderm |
Coordinate | chr1:235467740-235469290 |
Target genes | |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| Esrra | MA0592.2 | chr1:235468376-235468387 | TTGACCTTGAA | - | 6.14 | | LHX6 | MA0658.1 | chr1:235468367-235468377 | GCTAATTAGT | - | 6.02 |
|
| | Number of super-enhancer constituents: 5 | ID | Coordinate | Tissue/cell |
| SE_11774 | chr1:235467324-235469984 | CD20 | | SE_17529 | chr1:235467107-235469765 | CD4p_CD25-_CD45RAp_Naive | | SE_17897 | chr1:235466275-235469927 | CD4p_CD25-_CD45ROp_Memory | | SE_18709 | chr1:235467075-235469680 | CD4p_CD25-_Il17-_PMAstim_Th | | SE_62836 | chr1:235459648-235501055 | Tonsil |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr1 | 235467763 | 235468871 | | chr1 | 235468552 | 235468724 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH01I235304 | chr1 | 235467413 | 235469715 |
|
Enhancer Sequence | TGATTTAAAA GTGCAATTAC TCAAGGTCCC TTTTCATTAT CTTCTATAGC AATCCTTTAG 60
AAAATCATGT TAAACAGAAA AGCTGCCTAC TTAAAAAGTG AACTGTATCT TAGAGATTAA 120
GACAGATTCA AATCATAAAA CAAATTAAGA GTTAAGGGGC ACTCATCTGT TTTTCCACCA 180
TTGTGCTATA AATCATCACC ATCCTCATCA TGCAAAGGTC TGGAAAGGCT GAATTCTAAA 240
ACAAACATCT GCCTTTAGAA GAGTCAGGCA CTCAAATTGG AGTTTATCAA ACCCAGTGGT 300
TACCTTGGAG ACTACCCATC ACCACAAGCA TATACCTAGC AGATAAGATC AAGCAGAAAG 360
CATCTGCTAA TTAAGTGTAT TCTATGCATG GCCTGTCTGT ATTAGTACGT AATTTCCATC 420
TTCATAAAAT TCCTTTGTGG TAAATAGTAA ATACTAATCT CATTTTATAG CGAGGCCTAA 480
GAAGCTAAAT CATTTTGCCA CACTAAGGAA ACTCTGGTAG GCAGAATGCA CTCCCCCTCC 540
CCACAAAATG ACCACATCCG AATCTCCAAA ACATGTGAAA ATGTTATCTA TCAAGGGGAA 600
ATTTAAAGCT GACATGGAAT CAGAGTTGCT AATTAGTTGA CCTTGAAAGG GGGAGATTAG 660
CTTGTATTAT CTGGGTGAGC CCTATTTAAT ATAAACACAA GGATACTTAT AAGTGAAAGA 720
GGGAGGCAGG AGAGATAGTG TCAGAGACAG ATTTGAAGAC ACCAGGCTGC TGGCTTTGAA 780
AATAGGAGAG ACCAGAGGCA AAGGAGGAAA TACAGCCTCT AGAAGCTGGA AAAGAGGCAA 840
GGAAACCAAT TCTCCCCTAG AGCCTGAAGA AGAAATGCCC AGTGAGACCC ACGTCAGACC 900
TCTGACTTCC GGATTTGTTC AAAACTCCTC CCTCTCGATA CACACATAAA AACACACATA 960
CACTTACAAC TAACAACTCA CACAGTATTT GGCACTTCTA AATGTTCTGT GTACTAAGAA 1020
AACTAGATAT CCAAGTAAAG ATATATATTA AAGAGGCAGA AACAGCATTA ATATTAGTAG 1080
GAGCTCTGGT TTGAAGTAGT TTAGGTTTAA ATCCTCACTA TGCCACTTAC TAGTGGCATG 1140
ACCTTAGTTA GGTAAATTAT ATAATCTCTC TCGGCCTTGA GTTTTTCATC TGTAAAATAA 1200
GAATATATCT ATGTACCTCT CAGGGTATTT TGAGAATTAA AATTTTAAAT GGGCCAGGCA 1260
CGGGGACTCA CGCCTATAAT CCCAGCACTT TAGGAGGCAG AGGCAGGGGG ATCACTTGAA 1320
CCGGGGAGTT CAAGATCAGC CTAGGCAACA TAGTGAGACC CTGTCTCTAT GAAAAAAGTT 1380
AAAAATTCGC CAGGCATGGT GGTGGACACC TGTACTCCCA GCTACTCAGG AGGCTAAGGT 1440
GGGAGGATCA CCTGGGCCCA AGAGGTCAAG GTTACAGTCA GCCATGATCA CGCTACTATA 1500
TTCCTGCCCA GGCAACAGAG CAAGAAACTC TGTCTTCAAA TAAGAAAAAA 1550
|
